{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:43:42Z","timestamp":1780472622354,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.idc.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:41:57Z","timestamp":1663267317000},"page":"523-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early Lyme Disease (Erythema Migrans) and Its Mimics (Southern Tick-Associated Rash Illness and Tick-Associated Rash Illness)"],"prefix":"10.1016","volume":"36","author":[{"given":"Franc","family":"Strle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Wormser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2022.03.005_bib1","series-title":"Aspects of Lyme borreliosis","first-page":"1","article-title":"History","author":"Weber","year":"1993"},{"key":"10.1016\/j.idc.2022.03.005_bib2","series-title":"Lyme borreliosis","article-title":"The history, epidemiology, clinical manifestations and treatment of Lyme borreliosis","author":"Stanek","year":"2022"},{"issue":"4552","key":"10.1016\/j.idc.2022.03.005_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.idc.2022.03.005_bib4","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme disease in the United States and Europe","volume":"27","author":"Marques","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"suppl RR-10","key":"10.1016\/j.idc.2022.03.005_bib5","first-page":"20","article-title":"definitions for infectious conditions under public health surveillance: Lyme disease (revisited 9\/96)","volume":"46","author":"Case","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.idc.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. IDSA2006 Practice Guideline","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2022.03.005_bib8","series-title":"Lyme disease - relative frequency of clinical features among confirmed cases-United States, 2008\u20132019","year":"2021"},{"issue":"2","key":"10.1016\/j.idc.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.idc.2015.02.001","article-title":"Erythema migrans","volume":"29","author":"Nadelman","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","article-title":"An epidemiologic study of Lyme disease in southern Sweden","volume":"333","author":"Berglund","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2022.03.005_bib11","series-title":"Anon: epidemiologic surveillance of infectious diseases in Slovenia in 2018","year":"2019"},{"issue":"9","key":"10.1016\/j.idc.2022.03.005_bib12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/microorganisms9091872","article-title":"Epidemiological surveillance of Lyme borreliosis in Bavaria, Germany, 2013-2020","volume":"9","author":"B\u00f6hmer","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib13","doi-asserted-by":"crossref","first-page":"14976","DOI":"10.1038\/s41598-018-33136-0","article-title":"Incidence of notified Lyme borreliosis in Germany, 2013\u20132017","volume":"8","author":"Enkelmann","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ttbdis.2016.06.006","article-title":"Incidence and antibiotic treatment of erythema migrans in Norway 2005\u20132009","volume":"8","author":"Eliassen","year":"2017","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.idc.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","article-title":"The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans","volume":"100","author":"Nadelman","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2022.03.005_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-130-1-199901050-00006","article-title":"Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and Borrelia afzelii in Slovenia","volume":"130","author":"Strle","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2022.03.005_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","article-title":"Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans","volume":"136","author":"Smith","year":"2002","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.idc.2022.03.005_bib18","first-page":"1448","article-title":"Are differences in presentation of early Lyme borreliosis in Europe and North America a consequence of a more frequent spirochetemia in American patients?","volume":"10","author":"Maraspin","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.idc.2022.03.005_bib19","first-page":"506","article-title":"Clinical course, serologic response, and long-term outcome in elderly patients with early Lyme borreliosis","volume":"7","author":"Bor\u0161i\u010d","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.idc.2022.03.005_bib20","doi-asserted-by":"crossref","first-page":"e0250198","DOI":"10.1371\/journal.pone.0250198","article-title":"Characteristics of spirochetemic patients with a solitary erythema migrans skin lesion in Europe","volume":"16","author":"Maraspin","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.idc.2022.03.005_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(15)00464-8","article-title":"Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study","volume":"16","author":"Pritt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2022.03.005_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000213070","article-title":"Clinical manifestations and diagnosis of Lyme borreliosis","volume":"37","author":"Strle","year":"2009","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.idc.2022.03.005_bib23","first-page":"544","article-title":"Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia","volume":"114","author":"Ru\u017ei\u0107-Sablji\u0107","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.idc.2022.03.005_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1034\/j.1600-0463.2001.d01-178.x","article-title":"Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans","volume":"109","author":"Oksi","year":"2001","journal-title":"APMIS"},{"key":"10.1016\/j.idc.2022.03.005_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archderm.135.11.1329","article-title":"Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease","volume":"135","author":"Seinost","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.idc.2022.03.005_bib26","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1128\/JCM.43.5.2194-2200.2005","article-title":"Comparison of Borrelia burgdorferi sensu lato strains isolated from specimens obtained simultaneously from two different sites of infection in individual patients","volume":"43","author":"Ruzic-Sabljic","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2022.03.005_bib27","series-title":"Aspects of Lyme borreliosis","first-page":"70","article-title":"Histopathology of human Lyme borreliosis","author":"De Koning","year":"1993"},{"issue":"9","key":"10.1016\/j.idc.2022.03.005_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","article-title":"Hematogenous dissemination in early Lyme disease","volume":"142","author":"Wormser","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2022.03.005_bib29","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.idc.2022.03.005_bib30","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","article-title":"Lyme borreliosis","volume":"362","author":"Stanek","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2022.03.005_bib31","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1128\/IAI.00263-07","article-title":"Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma","volume":"75","author":"Mullegger","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/jix563","article-title":"Transcriptome assessment of erythema migrans skin lesions in patients with early Lyme disease reveals predominant interferon signaling","volume":"217","author":"Marques","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2022.03.005_bib33","first-page":"404","article-title":"Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii","volume":"31","author":"Logar","year":"2003","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.idc.2022.03.005_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/vbz.2010.0230","article-title":"Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii","volume":"11","author":"Strle","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.idc.2022.03.005_bib35","first-page":"524","article-title":"Children with multiple erythema migrans: are there any pre-treatment symptoms and\/or signs suggestive for central nervous system involvement?","volume":"114","author":"Arnez","year":"2002","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"10.1016\/j.idc.2022.03.005_bib36","first-page":"2364","article-title":"Course and outcome of erythema migrans in pregnant women","volume":"9","author":"Maraspin","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.idc.2022.03.005_bib37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2230.2006.02114.x","article-title":"The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients","volume":"31","author":"Furst","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.idc.2022.03.005_bib38","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1086\/504384","article-title":"Erythema migrans in solid-organ transplant recipients","volume":"42","author":"Maraspin","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.03.005_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/civ341","article-title":"Course and outcome of early Lyme borreliosis in patients with hematological malignancies","volume":"61","author":"Maraspin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.03.005_bib40","first-page":"285","article-title":"Penicillin treatment of erythema chronicum migrans Afzelius","volume":"38","author":"Hollstr\u00f6m","year":"1958","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"20","key":"10.1016\/j.idc.2022.03.005_bib41","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1114362","article-title":"Differentiation of reinfection from relapse in recurrent Lyme disease","volume":"367","author":"Nadelman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2022.03.005_bib42","series-title":"Aspects of Lyme borreliosis","first-page":"93","article-title":"Clinical features of Lyme borreliosis","author":"Weber","year":"1993"},{"issue":"23","key":"10.1016\/j.idc.2022.03.005_bib43","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1001\/jama.297.23.2617","article-title":"Does this patient have erythema migrans?","volume":"297","author":"Tibbles","year":"2007","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.idc.2022.03.005_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.2022.0081","article-title":"Diagnosis of Lyme disease","volume":"327","author":"Pitrak","year":"2022","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.idc.2022.03.005_bib45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432935","article-title":"Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions","volume":"41","author":"Wormser","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.03.005_bib46","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00238-06","article-title":"Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test","volume":"13","author":"Philipp","year":"2006","journal-title":"Clin Vaccin Immunol"},{"issue":"403","key":"10.1016\/j.idc.2022.03.005_bib47","doi-asserted-by":"crossref","first-page":"eaal2717","DOI":"10.1126\/scitranslmed.aal2717","article-title":"Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI)","volume":"9","author":"Molins","year":"2017","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.idc.2022.03.005_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/1346-8138.12594","article-title":"Case of tick-associated rash illness caused by Amblyomma testudinarium","volume":"41","author":"Natsuaki","year":"2014","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.idc.2022.03.005_bib49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jiac.2020.11.026","article-title":"Three cases diagnosed not Lyme disease but \"tick-associated rash illness (TARI)\" in Japan","volume":"27","author":"Moriyama","year":"2021","journal-title":"J\u00a0Infect Chemother"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib50","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the prevention, diagnosis and treatment of Lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.03.005_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/femsre\/fux047","article-title":"Lyme borreliosis-from tick bite to diagnosis and treatment","volume":"42","author":"Stanek","year":"2018","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"10.1016\/j.idc.2022.03.005_bib52","doi-asserted-by":"crossref","first-page":"e103188","DOI":"10.1371\/journal.pone.0103188","article-title":"Are patients with erythema migrans who have leukopenia and\/or thrombocytopenia coinfected with Anaplasma phagocytophilum or tick-borne encephalitis virus?","volume":"9","author":"Strle","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib53","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1186\/s12879-021-06755-8","article-title":"Tick-transmitted co-infections among erythema migrans patients in a general practice setting in Norway: a clinical and laboratory follow-up study","volume":"21","author":"Eliassen","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idc.2022.03.005_bib54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2022.03.005_bib55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.idc.2022.03.005_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the Early Manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2022.03.005_bib58","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.diagmicrobio.2018.01.025","article-title":"Is the risk of early neurologic Lyme borreliosis reduced by preferentially treating patients with erythema migrans with doxycycline?","volume":"91","author":"Strle","year":"2018","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:45Z","timestamp":1760196645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0891552022000356"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.03.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Lyme Disease (Erythema Migrans) and Its Mimics (Southern Tick-Associated Rash Illness and Tick-Associated Rash Illness)","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}